Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models
Page 1 of 1
Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models
Jon Moulton Fri Dec 04, 2015 2:57 pm
Schiffer M, Teng B, Gu C, Shchedrina VA, Kasaikina M, Pham VA, Hanke N, Rong S, Gueler F, Schroder P, Tossidou I, Park JK, Staggs L, Haller H, Erschow S, Hilfiker-Kleiner D, Wei C, Chen C, Tardi N, Hakroush S, Selig MK, Vasilyev A, Merscher S, Reiser J, Sever S. Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models. Nat Med. 2015 Jun;21(6):601-9. doi: 10.1038/nm.3843. Epub 2015 May 11.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Pharmacological induction of hypoxia-inducible transcription factor ARNT attenuates chronic kidney failure
» A novel SNP in the 5' regulatory region of organic anion transporter 1 is associated with chronic kidney disease
» Functional Analysis of Tmem63c in Zebrafish Reveals Its Role as a Novel Candidate for Albuminuria and Chronic Kidney Disease
» EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
» Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice
» A novel SNP in the 5' regulatory region of organic anion transporter 1 is associated with chronic kidney disease
» Functional Analysis of Tmem63c in Zebrafish Reveals Its Role as a Novel Candidate for Albuminuria and Chronic Kidney Disease
» EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
» Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum